Mumbai's S.L. Raheja Hospital Clocks 50 Transcatheter Aortic Valve Implantations (TAVI), Demonstrating Superiority in Minimally-Invasive Heart Interventions
S.L. Raheja Hospital's Interventional Cardiology Department Achieves 50 Successful TAVI Procedures
S.L. Raheja Hospital, a quaternary care center in Mumbai, has made significant headway in heart valve treatment with the successful completion of 50 Transcatheter Aortic Valve Implantation (TAVI) procedures. This milestone sets high benchmarks for the hospital's Structural Heart Program and positions it as a pioneer in cardiac care in the Mumbai region.
The TAVI procedures, led by Dr. Haresh Mehta, Director of Interventional Cardiology and Structural Heart Interventions, along with Consultants Dr. Kayan Siodia and Dr. Raghav Nagpal, have successfully catered to high-risk and elderly patients, offering a less invasive alternative to open-heart surgery for those with aortic stenosis. The team has demonstrated expertise in navigating complex cases, including bicuspid aortic valves and narrow femoral arteries, as well as performing trans carotid TAVIs in rare cases where femoral access was not feasible.
The benefits of TAVI are substantial, extending life expectancy and significantly improving the quality of life for patients with aortic stenosis. Dr. Haresh Mehta commented on the procedure, saying, "Severe symptomatic aortic stenosis can limit a patient's life expectancy to just 2-to-5 years. TAVI, the procedure used to treat this condition, can bring about life-altering changes as it extends life, and also dramatically improves quality of life."
The achievement underlines the hospital's dedication to delivering cutting-edge cardiac interventions and improving patient outcomes. S.L. Raheja Hospital offers a comprehensive range of advanced treatments beyond TAVI, including pacemaker implantation, structural heart interventions, and coronary angioplasties.
The Structural Heart Program at S.L. Raheja Hospital is designed to provide state-of-the-art cardiac therapies under one roof, ensuring patients receive the best possible care. The hospital is equipped with a modern Cath lab to support these advanced procedures.
Dr. Kunal Punamiya, CEO of S.L. Raheja Hospital, praised the team's achievements, stating, "This monumental achievement reflects our ongoing commitment to delivering cutting-edge cardiac interventions to those who need it the most. Our Structural Heart Program ensures [enhanced] outcomes, faster recovery, and [an] improved quality of life."
S.L. Raheja Hospital is affiliated with Fortis Healthcare Limited, a leading integrated healthcare services provider in India with numerous healthcare facilities and diagnostic centers across the country. Fortis employs over 23,000 people, drawing strength from its partnership with IHH Healthcare Berhad.
In adherence to global best practices for TAVI procedures, S.L. Raheja Hospital's team rigorously follows a multidisciplinary approach, careful patient selection, advanced imaging, and precise valve sizing to minimize complications and maintain optimal outcomes. Ongoing follow-up care is crucial in monitoring complications and ensuring the best possible patient care.
- The TAVI procedures led by Dr. Haresh Mehta at S.L. Raheja Hospital not only cater to high-risk patients with aortic stenosis but also significantly contribute to health-and-wellness by extending life expectancy and improving quality of life.
- As a pioneer in cardiac care, S.L. Raheja Hospital's Interventional Cardiology Department, with its Structural Heart Program, incorporates science and medical-conditions treatment into their endeavors, offering state-of-the-art cardiac therapies and ensuring enhanced culture of health for their patients.
- The successful completion of 50 Transcatheter Aortic Valve Implantation (TAVI) procedures at S.L. Raheja Hospital sets high benchmarks not only in cardiovascular-healthcare but also in health-and-wellness as they continue to uphold Fortis Healthcare Limited's mission of delivering cutting-edge medical-interventions for optimal patient outcomes.